Substance and method for reduction of lipids and cholesterol
CA 2280507 A1 · Owner: Kivekas, Olli · Inventors: Kivekas, Olli; Struszczyk, Henryk; Makinen, Elina
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Substance for reduction of absorption of lipids and for reduction of serum cholesterol content in mammals comprises microcrystalline chitosan. The microcrystalline chitosan can be administered orally in food products or in dose units containing a predetermined amount of microcrystalline chitosan. The microcrystalline chitosan has an average particle size not higher than 100 µm.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 5, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 5, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 5, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.